Robert Debre University Hospital — Clinical Trial Site

61 Registered trials

26 Currently recruiting

Organisation

Robert Debre University Hospital

Location

Paris, France

Identifier

ORG-100028699

Address

48 Boulevard Serurier, 75019, France

Departments

-
#1204:Service d’Hematologie-Immunologie Pediatrique
#2306:Pneumologie Pédiatrique et Allergologie
#3500:Service Hématologie-Immunologie
#40682: Service de Neurologie Pédiatrique
1000: Hématologie
3104:Pediatric Hematology
33006: Service Hématologie et immunologie Pédiatrique
75019
8002: Hématologie
Cardiologie pédiatrique
Centre d'Investigations Cliniques
Centre de reference des Maladies Constitutionnelles du Globule rouge et de l Erythropoiese
Centre Pédiatrique des Pathologies du Sommeil
Département d'endocrinologie pédiatrique et de diabète
Department of Pediatric Neurology and Metabolic Diseases
Endocrinologie et Diabétologie Pédiatrique
Gastroentérologie pédiatrique
Gynécologie Obstétrique
Hémato-immunologie pédiatrique
Hématologie
Hematologie pediatrique
Hematology
Hematology-Immunology
Hôpital Robert Debré
Immuno-hématologie pédiatrique
Immuno-hematology Pédiatric
N/A
Nephrologie pediatrique
Nephrology
Nephrology – Transplantion – Paediatric Haemodialysis
Nephrology pédiatrique
Nephrology Unit
Neurologie pédiatrique
Paediatrician / rheumatologist
Pediatric Endocrinology & Diabetology
Pediatric general
Pediatric Haematologist
Pediatric hemato- immunology Department
Pediatric Hematology
Pediatric nephrology
Pediatric Pneumology and Allergology
Pediatrics and cancer
Pédiatrie
Pneumologie, Allergologie, CRCM Pediatrique
Service d' Hématologie
Service d'endocrinologie diabétologie pédiatrique
Service d'hemato-immunologie
Service d'Hématologie Pédiatrique
Service d'immuno-hématologie pédiatrique
Service de Gastro-entérologie, Mucoviscidose, Pneumologie
Service de Néphrologie Pédiatrie
Service de nephrologie pediatrique
Service de Pédiatrie Générale
Service hématologie et Immunologie Pediatrique
Service reanimation et pédiatrie néonatales

Clinical trials at this site (61)

Search interface

Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the… Recruiting

2023-506721-11-00 Familial Mediterranean Fever (FMF) 5 2024-06-04
A study to investigate the efficacy and safety of tezepelumab compared with placebo in children 5 to < 12 years old with severe asthma Recruiting

2022-502984-39-00 Severe Uncontrolled Asthma Asthma (an illness that caus 5 2023-12-13
A study to assess efficacy and safety of benralizumab in paediatric patients with severe eosinophilic asthma (severe asthma marked by high… Recruiting

2022-501344-14-00 Paediatric Patients with Severe Eosinophilic Asthma Ast 5 2023-06-05
Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting

2022-500230-28-00 Highly sensitised paediatric patients with a positive c 4 2023-06-02
Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia. Recruiting

2023-508129-28-00 Pediatric patients with Philadelphia chromosome positiv 9 2022-09-28
An outpatient study to learn if Staccato Alprazolam is safe and effective when treating long seizures in children ≥12 years of age and adult… Recruiting

2024-510950-29-00 Stereotypical prolonged seizure 5 2022-07-21
CHASAP : Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy, a multicenter prospective randomized double-blind placebo-controlled t… Recruiting

2024-516461-36-00 Pregnancy associated hypertension, Pre-Eclampsia, Fetal 5 2021-01-27
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
A study to evaluate efficacy and safety of perampanel when administered together with other current antiepileptic medications in children wi… Recruiting

2023-507794-17-00 Childhood Epilepsy 4 2019-11-11
Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and Ad… Recruiting

2024-512321-84-00 Patients after HSCT suffering from new or reactivated C 5 2019-10-02
CAR T-cell therapy long term follow-up Recruiting

2023-508128-37-00 All patients who have been treated with Novartis or Pen 5 2017-07-19
Apremilast study in children with active oral ulcers associated with Behçet's Disease Ended

2023-503436-40-00 Behcet's disease 5 2024-11-11
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) Ended

2023-507655-30-00 Obesity 5 2024-09-27
Efficacy and safety of subcutaneous dupilumab in participants with asthma/asthmatic wheeze aged 2 to <6 years Ended

2023-504331-41-00 Respiratory tract diseases - Wheezing, Asthma 5 2024-08-02
Trial of efficacy and safety of MC0518 versus best available therapy in patients with steroid-refractory acute graft versus host disease Ended

2023-503952-28-00 Steroid refractory Acute Graft versus host Disease 4 2023-11-13
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Ended

2024-514173-22-00 Cystic Fibrosis 5 2023-02-28
This study is a randomized, placebo-controlled, double-blind, multicenter Phase 2/3 study of patients, age 12 to 65 years, with sickle cell … Ended

2024-511535-97-00 sickle cell disease (SCD) 10 2021-12-16
Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia Ended

2023-509170-33-00 Classic Congenital Adrenal Hyperplasia (CAH) 5 2021-11-23
A phase II trial of MK-3475 (pembrolizumab) in children and young adults with classical Hodgkin lymphoma Ended

2023-504821-38-00 Classical Hodgkin lymphoma in children and young adults 4 2019-09-19
Study for patients with Primary Hyperoxaluria to evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection Ended

2024-512260-54-00 Primary Hyperoxaluria 5 2019-08-20
Study of efficacy and safety of tisagenlecleucel in HR B-ALL EOC MRD positive patients Ended

2023-508081-15-00 High-risk B-cell acute lymphoblastic leukemia 4 2019-04-04
Myechild 01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Fin… Ended

2024-516112-21-00 Newly diagnosed acute myeloid leukaemia (AML), high ris 5 2017-11-20
A trial to understand if AZD0486 is safe and helps in people with Relapsed or Refractory B-cell acute lymphoblastic leukemia (B-ALL) Halted

2023-505840-20-00 B-Cell Acute Lymphoblastic Leukaemia 9 2024-08-16
A phase 1/2 study of subcutaneous blinatumomab administration in adults and adolescents with R/R and MRD+ B-ALL Halted

2023-506136-32-00 Relapsed or Refractory B cell Precursor Acute Lymphobla 9 2020-10-12